The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors (Q36923575)
Jump to navigation
Jump to search
scientific article published on June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors |
scientific article published on June 2013 |
Statements
1 reference
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors (English)
1 reference
Facundo Manes
1 reference
George T Grossberg
1 reference
Ricardo F Allegri
1 reference
Luis Miguel Gutiérrez-Robledo
1 reference
Sergio Gloger
1 reference
Lei Xie
1 reference
X Daniel Jia
1 reference
Vojislav Pejović
1 reference
Michael L Miller
1 reference
James L Perhach
1 reference
Stephen M Graham
1 reference
2 references
1 reference
1 reference
1 reference
Identifiers
1 reference